vs
Protalix BioTherapeutics, Inc.（PLX）与Spire Global, Inc.（SPIR）财务数据对比。点击上方公司名可切换其他公司
Spire Global, Inc.的季度营收约是Protalix BioTherapeutics, Inc.的1.7倍（$15.8M vs $9.1M），Protalix BioTherapeutics, Inc.净利率更高（-60.3% vs -176.6%，领先116.3%），Spire Global, Inc.同比增速更快（-26.9% vs -49.9%），Protalix BioTherapeutics, Inc.自由现金流更多（$1.6M vs $-16.2M），过去两年Protalix BioTherapeutics, Inc.的营收复合增速更高（-6.7% vs -32.6%）
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
Spire Global, Inc.是一家天基云数据与分析服务企业，核心业务依托由大量纳米卫星组成的卫星星座，提供覆盖全球的多领域数据集追踪服务，具体包含船舶航运追踪、航空航行监控以及气象模式观测等相关业务，服务覆盖全球范围。
PLX vs SPIR — 直观对比
营收规模更大
SPIR
是对方的1.7倍
$9.1M
营收增速更快
SPIR
高出23.0%
-49.9%
净利率更高
PLX
高出116.3%
-176.6%
自由现金流更多
PLX
多$17.8M
$-16.2M
两年增速更快
PLX
近两年复合增速
-32.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.1M | $15.8M |
| 净利润 | $-5.5M | $-28.0M |
| 毛利率 | 49.4% | 40.2% |
| 营业利润率 | -51.1% | -164.1% |
| 净利率 | -60.3% | -176.6% |
| 营收同比 | -49.9% | -26.9% |
| 净利润同比 | -184.8% | 42.7% |
| 每股收益（稀释后） | $-0.06 | $-0.85 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLXSPIR
| Q4 25 | $9.1M | $15.8M | ||
| Q3 25 | $17.9M | $12.7M | ||
| Q2 25 | $15.7M | $19.2M | ||
| Q1 25 | $10.1M | $23.9M | ||
| Q4 24 | $18.2M | $21.7M | ||
| Q3 24 | $18.0M | $28.6M | ||
| Q2 24 | $13.5M | $25.4M | ||
| Q1 24 | — | $34.8M |
净利润PLXSPIR
| Q4 25 | $-5.5M | $-28.0M | ||
| Q3 25 | $2.4M | $-19.7M | ||
| Q2 25 | $164.0K | $119.6M | ||
| Q1 25 | $-3.6M | $-20.7M | ||
| Q4 24 | $6.5M | $-48.8M | ||
| Q3 24 | $3.2M | $-12.5M | ||
| Q2 24 | $-2.2M | $-16.6M | ||
| Q1 24 | — | $-25.5M |
毛利率PLXSPIR
| Q4 25 | 49.4% | 40.2% | ||
| Q3 25 | 53.4% | 36.6% | ||
| Q2 25 | 62.5% | 48.9% | ||
| Q1 25 | 19.1% | 36.8% | ||
| Q4 24 | 78.7% | 32.4% | ||
| Q3 24 | 53.4% | 44.5% | ||
| Q2 24 | 29.8% | 43.0% | ||
| Q1 24 | — | 26.5% |
营业利润率PLXSPIR
| Q4 25 | -51.1% | -164.1% | ||
| Q3 25 | 11.9% | -166.1% | ||
| Q2 25 | 7.5% | -122.7% | ||
| Q1 25 | -41.0% | -106.5% | ||
| Q4 24 | 39.6% | -144.1% | ||
| Q3 24 | 22.2% | -48.0% | ||
| Q2 24 | -18.0% | -48.6% | ||
| Q1 24 | — | -34.4% |
净利率PLXSPIR
| Q4 25 | -60.3% | -176.6% | ||
| Q3 25 | 13.2% | -155.3% | ||
| Q2 25 | 1.0% | 623.4% | ||
| Q1 25 | -35.8% | -86.5% | ||
| Q4 24 | 35.6% | -225.2% | ||
| Q3 24 | 18.0% | -43.7% | ||
| Q2 24 | -16.4% | -65.2% | ||
| Q1 24 | — | -73.3% |
每股收益（稀释后）PLXSPIR
| Q4 25 | $-0.06 | $-0.85 | ||
| Q3 25 | $0.03 | $-0.61 | ||
| Q2 25 | $0.00 | $3.72 | ||
| Q1 25 | $-0.05 | $-0.77 | ||
| Q4 24 | $0.10 | $-1.93 | ||
| Q3 24 | $0.03 | $-0.50 | ||
| Q2 24 | $-0.03 | $-0.68 | ||
| Q1 24 | — | $-1.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $14.7M | $81.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $48.2M | $112.9M |
| 总资产 | $82.3M | $211.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PLXSPIR
| Q4 25 | $14.7M | $81.8M | ||
| Q3 25 | $13.6M | $96.8M | ||
| Q2 25 | $17.9M | $117.6M | ||
| Q1 25 | $19.5M | $35.9M | ||
| Q4 24 | $19.8M | $19.2M | ||
| Q3 24 | $27.4M | $36.6M | ||
| Q2 24 | $23.4M | $45.8M | ||
| Q1 24 | — | $63.7M |
总债务PLXSPIR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $103.7M | ||
| Q4 24 | — | $103.1M | ||
| Q3 24 | — | $4.9M | ||
| Q2 24 | — | $4.9M | ||
| Q1 24 | — | $123.1M |
股东权益PLXSPIR
| Q4 25 | $48.2M | $112.9M | ||
| Q3 25 | $52.9M | $133.1M | ||
| Q2 25 | $49.9M | $149.2M | ||
| Q1 25 | $45.2M | $3.7M | ||
| Q4 24 | $43.2M | $-11.7M | ||
| Q3 24 | $32.4M | $30.8M | ||
| Q2 24 | $28.6M | $40.3M | ||
| Q1 24 | — | $52.5M |
总资产PLXSPIR
| Q4 25 | $82.3M | $211.0M | ||
| Q3 25 | $82.3M | $224.3M | ||
| Q2 25 | $78.5M | $239.5M | ||
| Q1 25 | $73.9M | $208.8M | ||
| Q4 24 | $73.4M | $193.6M | ||
| Q3 24 | $61.6M | $224.2M | ||
| Q2 24 | $91.5M | $230.8M | ||
| Q1 24 | — | $252.3M |
负债/权益比PLXSPIR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 27.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 2.35× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.0M | $-4.3M |
| 自由现金流经营现金流 - 资本支出 | $1.6M | $-16.2M |
| 自由现金流率自由现金流/营收 | 17.8% | -102.1% |
| 资本支出强度资本支出/营收 | 4.4% | 75.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-13.6M | $-92.6M |
8季度趋势，按日历期对齐
经营现金流PLXSPIR
| Q4 25 | $2.0M | $-4.3M | ||
| Q3 25 | $-3.7M | $-12.0M | ||
| Q2 25 | $-5.2M | $-35.1M | ||
| Q1 25 | $-5.1M | $-8.4M | ||
| Q4 24 | $4.0M | $-19.2M | ||
| Q3 24 | $4.1M | $14.0M | ||
| Q2 24 | $-3.6M | $-4.4M | ||
| Q1 24 | — | $-8.8M |
自由现金流PLXSPIR
| Q4 25 | $1.6M | $-16.2M | ||
| Q3 25 | $-4.2M | $-20.4M | ||
| Q2 25 | $-5.7M | $-38.7M | ||
| Q1 25 | $-5.4M | $-17.3M | ||
| Q4 24 | $3.6M | $-24.3M | ||
| Q3 24 | $4.0M | $5.1M | ||
| Q2 24 | $-3.8M | $-9.9M | ||
| Q1 24 | — | $-15.9M |
自由现金流率PLXSPIR
| Q4 25 | 17.8% | -102.1% | ||
| Q3 25 | -23.7% | -161.3% | ||
| Q2 25 | -36.2% | -201.7% | ||
| Q1 25 | -53.0% | -72.6% | ||
| Q4 24 | 19.6% | -112.2% | ||
| Q3 24 | 22.4% | 17.8% | ||
| Q2 24 | -28.1% | -39.0% | ||
| Q1 24 | — | -45.7% |
资本支出强度PLXSPIR
| Q4 25 | 4.4% | 75.1% | ||
| Q3 25 | 2.8% | 66.2% | ||
| Q2 25 | 2.8% | 18.8% | ||
| Q1 25 | 3.0% | 37.3% | ||
| Q4 24 | 2.3% | 23.5% | ||
| Q3 24 | 0.5% | 31.2% | ||
| Q2 24 | 1.3% | 21.8% | ||
| Q1 24 | — | 20.3% |
现金转化率PLXSPIR
| Q4 25 | — | — | ||
| Q3 25 | -1.58× | — | ||
| Q2 25 | -31.91× | -0.29× | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.61× | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
SPIR
暂无分部数据
